Account
Concept Communications biggest gainer with Rs 300 million DLF Group IPO account : Period 6 – 19 April 2006
Indiantelevision.com and Spatial Access Solutions‘ newsletter — ‘Ad Accounts Action‘ — that will keep you abreast with all the creative and media accounts changing hands in the industry.
Spatial Access Solutions (SAS) is India‘s first media audit firm and hence, has a keen eye on all movements in the space. ‘Ad Accounts Action‘ is brought to you once every fortnight.
Given below is a listing of accounts that moved in the period 6 April – 19 April 2006.
Account name | Incumbent | New agency | Reported annual spends in Rs |
| Media | |||
Blue Star | Lodestar | Madison Media | 150 – 200 million |
Sony India | Starcom | Interactions | 250 million |
Star Cruises | Beehive Communications | Beehive Communications | 100 – 120 million |
Creative | |||
Dockers and Slates (Levi Strauss & Co) | – | Meridian Communications (Bangalore) | 40 – 60 million |
Fashion Station (Pantaloon Retail India) | Mudra | Marching Ants | 20 million |
Nitesh Estates | Grey Worldwide | Dentsu Communications (Bangalore) | 100 million |
Shoe Factory (Liberty & Pantaloons joint venture) | – | Mudra (Delhi) | 50 million |
Creative & Media | |||
China Airlines | O&M | Crayons Advertising (Delhi) | 20 million |
Chitralekha Group | – | Beehive Communications | 30 – 40 million |
DLF Group IPO | – | Concept Communications | 300 million |
TBZ Nirmal Zaveri Group | Flagship | Quadrant (Mumbai) | 30 – 50 million |
Dr Batra’s Positive Health Clinic | Euro RSCG (Mumbai) | Dattaram Advertising | 150 million |
| Information compiled by Spatial Access Solutions, India‘s first Media Audit Company. For information or clarifications email: info@spatialaccess.com, www.spatialaccess.com | |||
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
